Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.04% vs 11.72% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 59.15% vs -22.83% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 47.03% vs -17.21% in Dec 2025
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Kiniksa Pharmaceuticals International Plc With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.04% vs 11.72% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 55.52% vs 72.47% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 59.15% vs -22.83% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 165.88% vs 148.02% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 47.03% vs -17.21% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 118.38% vs 184.47% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






